Sign In
Buy ARIA
$23.99
+0 (+0%)
At Close: Mar 13, 2017
ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results
07:35am, Wednesday, 22'nd Jul 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its second quarter 2015 financial results on Wednesday, August 5, 2015, before the mar
ARIAD Reports First Quarter 2015 Financial Results and Progress on Strategic Objectives
07:35am, Thursday, 07'th May 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter of 2015, including revenue from sales of Iclusig® (ponatinib). The
ARIAD to Webcast Conference Call on First Quarter 2015 Financial Results
07:35am, Thursday, 23'rd Apr 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its first quarter 2015 financial results on Thursday, May 7, 2015, before the market o
ARIAD Reports 2014 Financial Results, Provides 2015 Financial Guidance and Outlines Strategic Objectives
07:35am, Thursday, 19'th Feb 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the fourth quarter and full year ended December 31, 2014 and issued 2015 financial gu
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2014 Financial Results
07:35am, Thursday, 29'th Jan 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its fourth quarter and year-end 2014 financial results and issue 2015 financial guidan
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results
07:35am, Wednesday, 15'th Oct 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its third quarter 2014 financial results on Wednesday, November 5, 2014, before the ma
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress
07:35am, Wednesday, 06'th Aug 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the second quarter of 2014, including revenue from sales of Iclusig® (ponatinib). Th
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results
07:35am, Wednesday, 16'th Jul 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before the mar
ARIAD Reports First Quarter 2014 Financial Results and Development Progress
07:35am, Wednesday, 07'th May 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and
